Results 101 to 110 of about 37,152 (268)

Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.

, 1978
Stefan Seifert, Thomas Gelehrter
openalex   +1 more source

Estimating the Factor VIII‐Equivalent Activity of Emicizumab Using Global Assays of Haemostasis

Haemophilia, EarlyView.
ABSTRACT Background Emicizumab is a bispecific monoclonal antibody mimicking factor (F) VIII activity and an effective therapy for prophylaxis in people with haemophilia A (PWHA). The FVIII‐equivalent activity (FVIIIeq) of emicizumab remains unknown. Objectives To estimate FVIIIeq of emicizumab using global assays of haemostasis.
Daniel Kraemmer, Cihan Ay, Judit Rejtő, Georg Heinze, Peter Quehenberger, Ingrid Pabinger, Oliver Königsbrügge   +6 more
wiley   +1 more source

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1. [PDF]

Data Brief, 2016
Gong L, Liu M, Zeng T, Shi X, Yuan C, Andreasen PA, Huang M.   +6 more
europepmc   +1 more source

Physiological activation of the human fibrinolytic system. Isolation and characterization of human plasminogen variants, Chicago I and Chicago II.

, 1979
Robert C. Wohl, Louis Summaria, Kenneth C. Robbins   +2 more
openalex   +1 more source

Regulation of Fibrinolysis Through Activation and Inhibition of Activation of a Plasminogen Proactivator (Preurokinase). [PDF]

, 1977
Maria B. Bernik, E.P. Oiler
openalex   +1 more source

Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study aimed to systematically review the literature on soluble biomarkers in adults with idiopathic intracranial hypertension (IIH). Background Idiopathic intracranial hypertension is a multifactorial disorder marked by elevated intracranial pressure without a clear cause.
Marina Romozzi, Fabio Zeoli, Renata Martinelli, Federico Tosto, Antonio Funcis, Giuseppe Garignano, Sabrina Chiloiro, Lucia Di Nardo, Catello Vollono, Alessandro Olivi, Paolo Calabresi, Francesco Signorelli   +11 more
wiley   +1 more source

Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1. [PDF]

J Biol Chem, 2015
Gong L, Liu M, Zeng T, Shi X, Yuan C, Andreasen PA, Huang M.   +6 more
europepmc   +1 more source

Myocardium as contributor of plasminogen activator to blood. [PDF]

, 1971
Ipseeta Menon, H. A. Dewar
openalex   +1 more source

Activation of the Urokinase Plasminogen Activator/Urokinase Plasminogen Activator Receptor System in Periodontitis: A Case–Control Study

International Journal of Dental Hygiene, EarlyView.
ABSTRACT Introduction The plasminogen activating (PA) system has a multitude of functions such as wound healing, proteolytic activity, collagen degradation and cell growth, and the role of the urokinase plasminogen activator/urokinase plasminogen activator receptor (uPA/uPAR) system has been studied in many disease states.
Ahmed Khudhur, Christopher Dowson, Susan M. Bissett, Rachel van de Merwe, John J. Taylor, Philip M. Preshaw, Katrin M. Jaedicke   +6 more
wiley   +1 more source

Novel Roles for Urokinase- and Tissue-Type Plasminogen Activators in the Pathogenesis of Mood Disorders. [PDF]

Int J Mol Sci
Bahi A, Steele S.
europepmc   +1 more source